What is LCHAD?

Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) is a rare genetic metabolic disorder that affects the body’s ability to break down certain fats for energy. It is part of a group of conditions known as fatty acid oxidation disorders (FAODs).

Because the body cannot properly convert long-chain fats into energy, individuals with LCHAD are at risk for serious medical complications, particularly during periods of fasting, illness, or increased physical stress.

How LCHAD Affects the Body

In individuals without LCHAD, long-chain fats are broken down and used as a key energy source—especially between meals or during times of increased demand. In individuals with LCHAD, this metabolic pathway does not function properly.

As a result, the body cannot reliably access fat for energy, leading to energy deficits and the buildup of toxic byproducts. This can place strain on multiple organ systems and increase the risk of metabolic crises.

Potential Complications

LCHAD can affect individuals differently, but possible complications may include:

  • Low blood sugar (hypoglycemia)

  • Muscle weakness or breakdown

  • Liver dysfunction

  • Heart complications

  • Vision impairment

  • Episodes of metabolic crisis requiring hospitalization

The severity and frequency of symptoms can vary widely and often depend on how well the condition is managed.

Daily Management

Managing LCHAD requires constant attention and careful planning. Treatment typically focuses on preventing the body from entering a metabolic state where fat breakdown is required for energy.

Management strategies may include:

  • Strict dietary planning

  • Frequent meals to avoid fasting

  • Medical nutrition

  • Ongoing monitoring by metabolic specialists

Even with careful management, unexpected illness or physical stress can trigger complications, making vigilance a daily requirement.

Why Research Matters

Because LCHAD is extremely rare, research into long-term outcomes, improved treatments, and potential cures remains limited. Much of the progress that has been made has relied on private funding rather than large-scale public investment.

Continued research is critical to:

  • Improve quality of life

  • Reduce the frequency and severity of complications

  • Develop better long-term treatment options

  • Explore potential curative approaches

This is where organizations like RISE for LCHAD play a vital role.

Learn More and Trusted Resources

For those looking to explore additional medical or clinical information, the following organizations provide reputable resources on LCHAD and related metabolic disorders: